Background: Preeclampsia remains a leading cause of maternal and perinatal morbidity and mortality, particularly in low- and middle-income countries (LMICs), where healthcare resources are limited. Understanding the spectrum of its complications is critical for early recognition...
Open access
Research Article10.9734/ajpcb/2025/v8i1159
Hormones mediate many body functions, including growth, differentiation, reproduction, and metabolism. There are variations in hormone release, response in different individuals, in relation to age, gender, stress situations, and body mass index. This article outlines the diagnos...
Open access
Research Article10.9734/jammr/2024/v36i105586
Background: Preeclampsia significantly contributes to maternal and perinatal illness and death, particularly in low and middle-income countries like Sudan. It is classified by onset timing (early vs. late) and severity (mild vs. severe) and is one of the four hypertensive disorde...
Open access
Research Article10.9734/ijbcrr/2024/v33i6900
Introduction: Breast cancer is a heterogeneous disease that cause women death. Several factors influence the development of breast cancer. Trace elements are associated with breast cancer risk factors. This study investigated six trace elements in red blood cells of women newly d...
Open access
Research Article10.9734/ijbcrr/2022/v31i10789
Introduction: Inflammatory mediators could be laboratory markers of preeclampsia, as the induction of an inflammatory process within the placenta may trigger the expression of cancer antigen 125(CA125), C-reactive protein (CRP) and uric acid (UA). Regarding the pathophysiology of...
Open access
Research Article10.9734/ijbcrr/2022/v31i10781
Preeclampsia is disorder unique to human pregnancy, defined by the international society of the study of hypertension in pregnancy (ISSHP). It causes significant maternal and neonatal morbidity and mortality. Measures to predict preeclampsia are very valuable for fetal and matern...
Open access
Research Article10.9734/ijbcrr/2023/v32i8833